Rare diseases
Investigational molecules
Locations
A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans
ItalyStudy of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation
ItalyStudy on the Effects of VS-01 for Adults with Acute-on-Chronic Liver Failure and Ascites
ItalyStudy of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy
ItalyStudy on the Effects of GSK3915393 for Patients with Idiopathic Pulmonary Fibrosis
ItalyStudy of Pembrolizumab with Chemotherapy for Patients with Gastric or Gastroesophageal Junction Cancer
ItalyStudy of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations
ItalyStudy Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer
ItalyStudy of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer
ItalyStudy of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation
ItalyStudy of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer After Trastuzumab Treatment
ItalyStudy of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
